These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6356272)

  • 1. The immunobiology of leishmaniasis.
    Pearson RD; Wheeler DA; Harrison LH; Kay HD
    Rev Infect Dis; 1983; 5(5):907-927. PubMed ID: 6356272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-Color Immunofluorescence Assay to Distinguish Intracellular From External
    Datta A; Barrie U; Wetzel DM
    Bio Protoc; 2024 Jun; 14(11):e5009. PubMed ID: 38873017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of co-stimulation in Leishmaniasis.
    Tuladhar R; Natarajan G; Satoskar AR
    Int J Biol Sci; 2011; 7(9):1382-90. PubMed ID: 22110389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to Intracellular Infections: Contributions of TNF to Immune Defense.
    Li X; Körner H; Liu X
    Front Microbiol; 2020; 11():1643. PubMed ID: 32760383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Emerging Approach for Parallel Quantification of Intracellular Protozoan Parasites and Host Cell Characterization Using TissueFAXS Cytometry.
    Schmid M; Dufner B; Dürk J; Bedal K; Stricker K; Prokoph LA; Koch C; Wege AK; Zirpel H; van Zandbergen G; Ecker R; Boghiu B; Ritter U
    PLoS One; 2015; 10(10):e0139866. PubMed ID: 26488169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis.
    Kaur T; Thakur A; Kaur S
    J Parasit Dis; 2013 Oct; 37(2):231-9. PubMed ID: 24431576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the polymerase chain reaction in the diagnosis of clinically suspected cases of American visceral leishmaniasis.
    Pedrosa CM; Ximenes RA; Almeida WA; Rocha EM
    Braz J Infect Dis; 2013; 17(3):319-23. PubMed ID: 23683573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the arginase, 5'-nucleotidase and lysozyme activity by monocytes from visceral leishmaniasis patients.
    Kumar P; Kumar R; Pandey H; Sundar S; Pai K
    J Parasit Dis; 2012 Apr; 36(1):19-25. PubMed ID: 23542635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.
    Ghosh J; Lal CS; Pandey K; Das VN; Das P; Roychoudhury K; Roy S
    Ann Trop Med Parasitol; 2011 Apr; 105(3):267-71. PubMed ID: 21801506
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus and Leishmania donovani coinfection in a renal allograft recipient.
    Prasad N; Gupta A; Sharma RK; Gopalakrishnan S; Agrawal V; Jain M
    Indian J Nephrol; 2011 Apr; 21(2):128-31. PubMed ID: 21769179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of macrophage source on the mechanism of phagocytosis and intracellular survival of Leishmania.
    Hsiao CH; Ueno N; Shao JQ; Schroeder KR; Moore KC; Donelson JE; Wilson ME
    Microbes Infect; 2011 Nov; 13(12-13):1033-44. PubMed ID: 21723411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-cell lipid rafts: a safe door for micro-organisms?
    Vieira FS; Corrêa G; Einicker-Lamas M; Coutinho-Silva R
    Biol Cell; 2010 Apr; 102(7):391-407. PubMed ID: 20377525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasi.
    Hsiao CH; Yao C; Storlie P; Donelson JE; Wilson ME
    Mol Biochem Parasitol; 2008 Feb; 157(2):148-59. PubMed ID: 18067978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology.
    Forgber M; Basu R; Roychoudhury K; Theinert S; Roy S; Sundar S; Walden P
    PLoS One; 2006 Dec; 1(1):e40. PubMed ID: 17183669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunology of parasite infections in immunocompromised hosts.
    Evering T; Weiss LM
    Parasite Immunol; 2006 Nov; 28(11):549-65. PubMed ID: 17042927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complex antigens as a tool in serodiagnosis of kala-azar.
    Chakraborti T; Sarkar D; Ghosh DK
    Mol Cell Biochem; 2003 Nov; 253(1-2):191-8. PubMed ID: 14619969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular release of the surface metalloprotease, gp63, from Leishmania and insect trypanosomatids.
    Jaffe CL; Dwyer DM
    Parasitol Res; 2003 Oct; 91(3):229-37. PubMed ID: 12923634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis.
    Kumar R; Pai K; Sundar S
    Clin Exp Immunol; 2001 May; 124(2):262-5. PubMed ID: 11422203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.
    Mukhopadhyay S; Bhattacharyya S; Majhi R; De T; Naskar K; Majumdar S; Roy S
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):233-40. PubMed ID: 10702498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.
    Power CA; Wei G; Bretscher PA
    Infect Immun; 1998 Dec; 66(12):5743-50. PubMed ID: 9826349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.